704 related articles for article (PubMed ID: 8248106)
1. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells.
Fadare O
Pathol Int; 2006 Nov; 56(11):683-7. PubMed ID: 17040292
[TBL] [Abstract][Full Text] [Related]
3. Primary signet-ring cell/histiocytoid carcinoma of the eyelid: a clinicopathologic study of 5 cases and review of the literature.
Requena L; Prieto VG; Requena C; Sarasa JL; Manzano R; Seco M; Rütten A; Kazakov DV; Cerroni L; Kutzner H
Am J Surg Pathol; 2011 Mar; 35(3):378-91. PubMed ID: 21317710
[TBL] [Abstract][Full Text] [Related]
4. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases.
Bentz JS; Yassa N; Clayton F
Mod Pathol; 1998 Sep; 11(9):814-22. PubMed ID: 9758360
[TBL] [Abstract][Full Text] [Related]
5. Signet-ring cell variant of invasive lobular carcinoma of the breast. A clinicopathologic study of 11 cases.
Eltorky M; Hall JC; Osborne PT; el Zeky F
Arch Pathol Lab Med; 1994 Mar; 118(3):245-8. PubMed ID: 8135627
[TBL] [Abstract][Full Text] [Related]
6. The significance of signet ring cells in infiltrating lobular carcinoma of the breast.
Frost AR; Terahata S; Yeh IT; Siegel RS; Overmoyer B; Silverberg SG
Arch Pathol Lab Med; 1995 Jan; 119(1):64-8. PubMed ID: 7802556
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor 4A expression discriminates gastric involvement by metastatic breast carcinomas from primary gastric adenocarcinomas.
Koyama T; Sekine S; Taniguchi H; Tsuda H; Ikegami M; Hano H; Kushima R
Hum Pathol; 2011 Nov; 42(11):1777-84. PubMed ID: 21733563
[TBL] [Abstract][Full Text] [Related]
10. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
Chia SY; Thike AA; Cheok PY; Tan PH
Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
[TBL] [Abstract][Full Text] [Related]
11. Gastric metastasis of mammary signet ring cell carcinoma--a differential diagnosis with primary gastric signet ring cell carcinoma.
Yim H; Jin YM; Shim C; Park HB
J Korean Med Sci; 1997 Jun; 12(3):256-61. PubMed ID: 9250925
[TBL] [Abstract][Full Text] [Related]
12. Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
Langel DJ; Yeatts RP; White WL
Am J Dermatopathol; 2001 Oct; 23(5):444-9. PubMed ID: 11801778
[TBL] [Abstract][Full Text] [Related]
13. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
Rosa M; Mohammadi A; Masood S
Pathol Int; 2009 Jun; 59(6):405-9. PubMed ID: 19490472
[TBL] [Abstract][Full Text] [Related]
14. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression.
Nowak MA; Guerriere-Kovach P; Pathan A; Campbell TE; Deppisch LM
Arch Pathol Lab Med; 1998 Dec; 122(12):1077-81. PubMed ID: 9870855
[TBL] [Abstract][Full Text] [Related]
15. Breast metastases of gastric signet ring cell carcinoma: a differential diagnosis with primary breast signet ring cell carcinoma.
Qureshi SS; Shrikhande SV; Tanuja S; Shukla PJ
J Postgrad Med; 2005; 51(2):125-7. PubMed ID: 16006706
[TBL] [Abstract][Full Text] [Related]
16. Mammary origin of metastases. Immunohistochemical determination.
Chaubert P; Hurlimann J
Arch Pathol Lab Med; 1992 Nov; 116(11):1181-8. PubMed ID: 1444749
[TBL] [Abstract][Full Text] [Related]
17. Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers.
Hui Y; Wang Y; Nam G; Fanion J; Sturtevant A; Lombardo KA; Resnick MB
Hum Pathol; 2018 Jul; 77():11-19. PubMed ID: 29317235
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.
Yan Z; Gidley J; Horton D; Roberson J; Eltoum IE; Chhieng DC
Diagn Cytopathol; 2009 Jul; 37(7):475-8. PubMed ID: 19217055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
